Skip to content
No picture yet

Itovebi 3 mg – DIN 02555476

Itovebi is Inavolisib 3 mg (tablet), sold in Canada. It is used for breast cancer. It is supplied by Hoffmann-LA Roche Limited. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Inavolisib 3 mg

Brand
Itovebi
Strength
3 mg
Used for
Breast cancer
Form
Tablet
Manufacturer
Hoffmann-LA Roche Limited
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02555476

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Inavolisib pills and guides

What is Inavolisib used for?

Inavolisib is used for breast cancer.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

ITOVEBI, in combination with palbociclib and fulvestrant, is indicated for the treatment of adults with endocrine-resistant, PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer, as detected by an FDA-approved test, following recurrence on or after completing adjuvant endocrine therapy.

From the FDA-approved label on DailyMed (published Apr 28, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02555476.
  • It names Itovebi, Inavolisib 3 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Itovebi by Hoffmann-LA Roche Limited.

In Canada: PRESCRIPTION RECOMMENDED.

Ingredients

Active: Inavolisib

Other Inavolisib pills